Skip to content
Open access

Salivary Metabolomics: A Pilot Study for Screening Biomarkers in Mild-to-moderate Periodontitis

Aug 2026 · In Vivo · Vol 40, pp. 2960 - 2972 · 0 citations · 33 references
Medicine

TL;DR

Salivary metabolites, including O-acetylcarnitine, tyrosine, and histidine, may serve as potential non-invasive biomarkers for mild-to-moderate periodontitis.

Abstract

Background/Aim: This study aims to identify salivary metabolites that can discriminate patients with mild and moderate periodontitis from healthy controls through comprehensive metabolomic analyses using capillary electrophoresis-mass spectrometry (CE-MS). Patients and Methods: Forty healthy controls, 40 patients with mild periodontitis, and 40 patients with moderate periodontitis were enrolled. Whole unstimulated saliva samples were collected from the participants, and CE-MS was used to comprehensively analyze salivary metabolites. Furthermore, a multiple logistic regression (MLR) model was developed using multiple candidate metabolites, and the combinations of metabolites with the highest area under the curve (AUC) were identified. Results: The concentrations of 34 metabolites significantly differed between the mild/moderate periodontitis group and healthy controls. Of these, three were used to develop the MLR model: O-acetylcarnitine, tyrosine, and histidine. The AUC value based on the combination of these three metabolites was 0.867 (sensitivity: 0.73, specificity: 0.90, 95% confidence interval=0.804-0.929, p<0.001) for discriminating between patients with mild and moderate periodontitis and healthy controls. Conclusion: Salivary metabolites, including O-acetylcarnitine, tyrosine, and histidine, may serve as potential non-invasive biomarkers for mild-to-moderate periodontitis.

Read PDF

Similar papers

Open access Sep 2026

Oral microbiome–metabolome axis links glycerophospholipid dysregulation to Alzheimer’s disease

ABSTRACT Introduction This study aimed to evaluate the feasibility of using tongue biofilm as a non-invasive, patient-friendly, and cost-effective biomarker source for identifying early microbial and metabolic disturbances associated with Alzheimer’s disease (AD). Materials and methods A total of 62 outpatients were en...

Meng-Qi Jia, Run-Juan Yang, Ying Xu et al. · 0 citations
Open access Aug 2026

Periodontitis in a Large Cohort of Young Chinese Adults: Associated Factors and Salivary Microbiome–Metabolome Profiles

Introduction and aims Periodontitis is a chronic multifactorial inflammatory disease that damages periodontal tissues and is associated with systemic diseases. It shows a global younger onset trend, with rising incidence in Chinese young adults, but studies mostly focus on those ≥35 years, lacking systematic exploratio...

Hantao Huang, Jia-Hui Sun, Meng-Xi Zhai et al. · 0 citations
Open access Sep 2026

Analysis of Plasma Biomarkers and Potential Pathogenesis in Children with Mycoplasma pneumoniae Pneumonia Based on Metabolomic Technology

Background Mycoplasma pneumoniae pneumonia (MPP) is a common cause of community-acquired pneumonia in children, yet its metabolic alterations and pathogenic mechanisms remain incompletely understood. This study aimed to characterize the plasma metabolomic profile of children with MPP and explore associated metabolic pa...

Qiu-Yan Xu, Li Shen, Lei Hong et al. · 0 citations
Review Open access Aug 2026

Salivary Metabolomics for Oral Squamous Cell Carcinoma Detection: An Indian Perspective

Salivary metabolomics has emerged as a promising noninvasive approach for the early detection of oral squamous cell carcinoma (OSCC), enabling the identification of tumor-associated metabolic alterations with potential diagnostic value. Recent systematic reviews and meta-analyses have demonstrated encouraging diagnos...

Raghuram Manickam, V. Subramani · 0 citations
Open access Sep 2026

Metabolic differences among patients with alcohol-related liver disease using targeted and untargeted metabolomics techniques

Serum levels of five DEMs (Glu, Pro, Orn, Cit, Cit, and Arg) are closely linked to ALD-related metabolic dysregulation; they serve as potential indicators of ALD progression and provide valuable insights for the clinical staging and targeted intervention of ALD.

Jie-Sen Lu, Li Zhao, Tian-Yi Zhu et al. · 0 citations
Open access Aug 2026

Metabolic profiling of severe early childhood caries and black stain: pathway and biomarker discovery in 3-6-year-olds

The present study aims to identify the key metabolic compounds of supragingival plaque and potential metabolic pathways associated with severe early childhood caries (S-ECC) in preschool children, and to provide a basis for screening candidate biomarkers that could be beneficial to clinical practice guidelines. A cohor...

Ying Chen, Jing Xie, Li Chen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.